The safety and efficacy of streptokinase in coronary reperfusion in patients with acute myocardial infarction.
作者信息
Hu D
机构信息
Research Center for Heart Diseases, Beijing Red Cross Chaoyang Hospital.
出版信息
Chin Med J (Engl). 1995 Apr;108(4):291-4.
PMID:7789218
Abstract
摘要
相似文献
1
The safety and efficacy of streptokinase in coronary reperfusion in patients with acute myocardial infarction.链激酶在急性心肌梗死患者冠状动脉再灌注中的安全性和有效性。
Chin Med J (Engl). 1995 Apr;108(4):291-4.
2
Assessment of intravenous streptokinase therapy in acute myocardial infarction.急性心肌梗死静脉注射链激酶治疗的评估
J Assoc Physicians India. 1993 Jun;41(6):333-4.
3
Streptokinase in acute myocardial infarction: a multicentric study in an Indian setting. Streptokinase Multicentric Trial Group.
Indian Heart J. 1993 May-Jun;45(3):189-94.
4
Accelerated streptokinase--a new thrombolytic regimen in acute myocardial infarction.加速链激酶——急性心肌梗死的一种新溶栓方案。
Rom J Intern Med. 1998 Jul-Dec;36(3-4):183-96.
5
6
[Mechanical reperfusion in acute myocardial infarction after failure of thrombolysis with intravenous streptokinase].
Rev Med Chil. 1993 Oct;121(10):1161-73.
7
8
Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
Chin Med J (Engl). 2000 Aug;113(8):733-6.
9
10
Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.急性心肌梗死静脉输注链激酶后发生急性肾衰竭。
West J Med. 1993 Apr;158(4):406-9.
Zotero 插件